What if one of the most basic ideas in nutrition — that a calorie is a calorie — is the wrong way to think about metabolic health?

For decades, Robert Lustig has argued that obesity, diabetes and other chronic metabolic diseases cannot be understood through energy balance alone. His central argument: what happens to food after we eat it matters, and added sugar — particularly fructose — can disrupt metabolic function in ways calorie counting fails to capture.

In this episode of Return on Health, hosts Niko Hems and Miguel Medina challenge Robert on how strong that case actually is. They discuss his research on sugar restriction, controlled feeding trials that appear to contradict some of his conclusions, food-industry influence on nutrition science, ultra-processed food, agricultural subsidies and the incentives shaping what we eat.

The conversation also turns to Ozempic, Wegovy and other GLP-1 drugs.

━━━━👤 ABOUT THE GUEST━━━━━

Robert H. Lustig, MD, MSL is a pediatric endocrinologist and Professor Emeritus of Pediatrics at UCSF.

He spent decades researching childhood obesity, diabetes and metabolic disease. His 2009 lecture “Sugar: The Bitter Truth” has been watched more than 25 million times on YouTube and made him one of the most prominent and debated voices in nutrition.

He is also the author of Metabolical, Fat Chance, and The Hacking of the American Mind.

━━━━🎙️ ABOUT THE HOSTS━━━━

Niko Hems is Head of Strategy & Medical Communications at YEARS, a preventive medicine company using longitudinal and multi-modal health data to make prevention more personalized and data-driven.

Miguel Medina is co-host of Return on Health, a podcast built around a simple idea: a system produces the outcomes it is incentivized to produce — so better health outcomes require better incentives.

━━━━⏱ CHAPTERS━━━━━

00:00 Who Is Robert Lustig?
00:52 What Is Metabolic Disease?
04:02 Mitochondrial Dysfunction Explained
09:11 What Does Metabolism Actually Mean?
10:45 Is “A Calorie Is A Calorie” Wrong?
15:35 Why Robert Thinks Fructose Damages Mitochondria
17:08 What Happened When His Team Removed Added Sugar?
22:49 Niko Challenges Robert On Contradictory Fructose Studies
29:23 Does Food Industry Funding Distort Nutrition Research?
33:10 How The Food Industry Shapes Science
35:20 The Center To End Corporate Harm
38:23 How Do We Fix The Food System?
41:18 What Can Ordinary People Actually Do?
44:50 Microplastics, PFAS & Other Metabolic Exposures
48:02 Can We Feed 10 Billion People Without Ultra-Processed Food?
51:47 The Most Underrated Metabolic Biomarker
52:45 Why Robert Refuses To Share His Personal Diet
53:14 What Foods Should People Eat More — And Less — Of?
54:46 What Robert Lustig Changed His Mind About
56:59 What Would He Change About US Food Policy?
58:09 How Food Subsidies Shape What We Eat
01:01:50 Robert Lustig On Ozempic, Wegovy & GLP-1 Drugs
01:04:35 The Potential Downsides Of GLP-1s
01:08:30 Why Robert Says We Still Have To Fix The Food
01:09:35 What Should Change About Healthcare?

━━━━━💡 KEY QUESTIONS ANSWERED━━━━━

• Is “a calorie is a calorie” biologically misleading?
• Why does Robert consider fructose different from glucose?
• What happened when his team restricted sugar without reducing calories?
• Why do some controlled feeding trials reach different conclusions?
• Does food-industry funding distort nutrition research?
• How much does ultra-processed food contribute to metabolic disease?
• Is fasting insulin an underrated biomarker?
• How do food subsidies influence what we eat?
• Are Ozempic and Wegovy solving obesity or treating the symptom?
• What concerns does Robert have about widespread GLP-1 use?
• Why does he think healthcare should spend far more on prevention?

━━━━━━━━━━━━━━━

Connect with Robert:

Website: https://robertlustig.com/
LinkedIn: https://www.linkedin.com/in/robert-lustig-8904245/
UCSF: https://profiles.ucsf.edu/robert.lustig

What if aging is less like an inevitable biological process.. and more like damage that can eventually be repaired?

For more than two decades, Aubrey de Grey has argued that aging should be treated as a medical problem driven by the accumulation of molecular and cellular damage. His most famous idea, longevity escape velocity.

In this episode of Return on Health, hosts Niko and Miguel challenge Aubrey on how realistic that vision actually is, what his latest mouse rejuvenation experiments can tell us about humans, why his first major study fell short of its ultimate goal, and what would have to happen before rejuvenation becomes real medicine.

Aubrey also explains why he believes aging can be approached through repair, why combining interventions may matter more than testing them one by one, why current biological age clocks are still limited, what he thinks the Hallmarks of Aging get wrong, and why he believes the first person to live to 1,000 years has probably already been born.

━━━━👤 ABOUT THE GUEST━━━━━

Aubrey de Grey is a biomedical gerontologist and one of the most prominent voices in longevity science. He is the founder and President of the Longevity Escape Velocity Foundation, where his work focuses on developing and testing combinations of rejuvenation therapies aimed at repairing different forms of age-related damage.

He is also known for developing the SENS framework and popularizing the concept of longevity escape velocity: the idea that sufficiently effective rejuvenation therapies could extend healthy life long enough for progressively better therapies to arrive.

━━━━🎙️ ABOUT THE HOSTS━━━━

Niko Hems is a longevity expert and Head of Growth at YEARS, a company building a longitudinal, multi-modal health dataset to make prevention personal and data-driven.

Miguel Medina is co-host of Return on Health, a podcast built on a simple idea: a system always produces the outcomes it's incentivized to produce.

━━━━⏱ CHAPTERS━━━━━

00:00 Is Aging Actually A Disease?

02:17 Aubrey's Latest Mouse Rejuvenation Study

08:23 What Actually Counts As Age-Related Damage?

13:59 Can Mouse Longevity Research Translate To Humans?

16:25 How Do We Measure Anti-Aging Effects In Humans?

20:36 Can The First Person To Live To 1,000 Already Be Alive?

23:18 Longevity Escape Velocity Explained

28:16 Did Aubrey's First Mouse Rejuvenation Study Work?

32:11 How Do You Choose Which Longevity Interventions To Combine?

37:37 SENS vs The Hallmarks Of Aging

43:32 What Has Aubrey Changed His Mind About?

45:39 What Should People Actually Do Today?

47:54 Why Longevity Research Struggles To Get Funded

53:32 Prevention vs Rejuvenation

55:35 What Aubrey Would Change About Science

57:16 The Strongest Argument That Aging Can Be Repaired

58:08 Aubrey's Personal Longevity Protocol

58:41 Are Biological Age Clocks Actually Useful?

01:00:18 How Should Healthcare Change?

━━━━━💡 KEY QUESTIONS ANSWERED━━━━━

• Is aging actually a disease?

• What does Aubrey de Grey mean by accumulated biological damage?

• Can age-related damage actually be repaired?

• What is longevity escape velocity?

• Could the first person to live to 1,000 already be alive?

• What happened in Aubrey's first robust mouse rejuvenation experiment?

• Why is he now testing a combination of eight interventions?

• Can longevity results in mice realistically translate to humans?

• How can we test rejuvenation therapies without waiting decades for mortality data?

• What is the difference between the SENS framework and the Hallmarks of Aging?

• Are biological age and epigenetic clocks reliable enough for clinical trials?

• What has Aubrey changed his mind about after more than two decades?

• Why does he think current research funding creates the wrong incentives?

━━━━━━━━━━━━━━━

Connect with Aubrey:

Longevity Escape Velocity Foundation: https://www.levf.org/

X / Twitter: https://x.com/aubreydegrey

LinkedIn: https://www.linkedin.com/in/aubrey-de-grey-24260b/

What if one of the most popular ideas about cancer is simply wrong?

For years, social media has promoted the idea that cancer is primarily a metabolic disease - one that can be starved, hacked, or even reversed through diet. But cancer geneticist Dr Moritz Przybilla argues that decades of genomic research tell a very different story.

In this episode of Return on Health, hosts Niko Hems and Miguel Medina explore why cancer is fundamentally a disease of DNA, why aging remains its greatest risk factor, what the evidence really says about ketogenic diets and sugar, and where cancer research is genuinely moving next.

Moritz also explains why most people misunderstand cancer prevention, why early detection may save far more lives than chasing miracle cures, how healthy tissues quietly accumulate mutations throughout life, and why the future of cancer medicine may lie in predicting risk decades before a tumor ever appears.

━━━━👤 ABOUT THE GUEST━━━━━

Dr. Moritz Jakob Przybylla is a cancer researcher at the Wellcome Sanger Institute in Cambridge. His research focuses on cancer genomics, early cancer evolution, and developing new approaches for cancer risk prediction, prevention, and early detection. Alongside his research, Moritz is passionate about making cancer science accessible and combating misinformation with evidence-based education.

━━━━🎙️ ABOUT THE HOSTS━━━━

Niko HemsNiko Hems is a longevity expert and Head of Growth at YEARS, a company building a longitudinal, multi-modal health dataset to make prevention personal and data-driven.

Miguel MedinaMiguel Medina is co-host of Return on Health, a podcast built on a simple idea: a system always produces the outcomes it's incentivized to produce - so if we want better health outcomes, we need better incentives.

━━━━⏱ CHAPTERS━━━━━

00:00 The Biggest Cancer Myth

00:57 Meet Cancer Geneticist Dr. Moritz Gerstung

02:04 Why He Left The Lab To Build A Public Voice

07:58 What Cancer Actually Is (Explained Simply)

12:21 Can You Really Prevent Cancer?

15:32 Which Infections Increase Cancer Risk?

17:15 Driver vs Passenger Mutations Explained

19:57 Thomas Seyfried's Metabolic Theory Of Cancer

28:49 Do Ketogenic Diets Help Treat Cancer?

32:59 Are 60% Of Cancers Really Unpreventable?

41:18 Metformin, Aging & Cancer Prevention

43:07 If We Could Slow Aging, Would We Prevent Cancer?

46:14 The Most Overhyped Cancer & Longevity Trends

47:11 Which Cancer Screening Test Should You Actually Get?

48:16 Moritz's Dream Cancer Research Project

49:35 How Healthcare Should Change

━━━━━💡 KEY QUESTIONS ANSWERED━━━━━

• Is cancer really a genetic disease?• Is the metabolic theory of cancer supported by current evidence?• Can sugar actually "feed" cancer?• Does the ketogenic diet help treat cancer?• Why are around 60% of cancers currently unavoidable?• Why is aging the biggest risk factor for cancer?• What are driver mutations and passenger mutations?• Can we predict cancer decades before it develops?• Which cancer screening tests are actually worth doing?• What is the future of cancer prevention?• How should healthcare shift from treating disease to preventing it?

━━━━━━━━━━━━━━━

Connect with Moritz:

Linkedin: https://www.linkedin.com/in/moritz-jakob-przybilla/?locale=en

Instagram: https://www.instagram.com/dr.moritzprzy/?hl=en

Most people think aging is a disease.

Professor Suresh Rattan thinks that's one of the biggest misconceptions in modern medicine.

The anti-aging industry has never been bigger. Every week there's a new supplement, a new biomarker, a new longevity protocol, or another promise that you can slow, reverse, or even cure aging.

But after more than 40 years studying the biology of aging, Suresh has reached a very different conclusion.

Aging isn't something to cure. It's something to understand.

In this episode of Return on Health, hosts Niko Hems and Miguel Medina sit down with one of the world's leading biogerontologists to challenge everything we think we know about aging, longevity, and health.

We explore why Suresh believes there are no genes programmed to make us age, why the anti-aging industry is selling false promises, what he really thinks about Bryan Johnson, David Sinclair, and longevity escape velocity, and why living well may matter far more than simply living longer.

━━━━━👤 ABOUT THE GUEST ━━━━━

Professor Suresh I.S. Rattan is one of the world's leading biogerontologists, with more than four decades of research into the biology of aging.

He founded the Laboratory of Cellular Ageing at Aarhus University in Denmark, coined the term "gerontogenes", founded the journal Biogerontology, and has published hundreds of scientific papers exploring why we age and what healthy aging really means.

His work challenges many of the assumptions driving today's longevity industry, arguing that aging is a natural consequence of life - not a disease to be cured.

━━━━━━🎙️ ABOUT THE HOSTS ━━━━━━

Niko Hems

Niko Hems is a longevity expert and Head of Growth at YEARS, a company building a longitudinal, multi-modal health dataset to make prevention personal and data-driven.

Miguel Medina

Miguel Medina is co-host of Return on Health, a podcast built on a simple idea: a system always produces the outcomes it's incentivized to produce - so if we want better health outcomes, we need better incentives.

━━━━━⏱ CHAPTERS ━━━━━━

00:00 Aging Is Not a Disease

01:39 Why the Longevity Industry Is Selling Products

03:32 Do We Actually Understand Aging?

08:40 Why Aging Isn't a Disease

18:22 The Truth About the Hallmarks of Aging

19:12 How Humans Already Doubled Their Lifespan

23:15 Bryan Johnson, David Sinclair & Living Forever

27:52 What Actually Helps You Age Better?

35:59 What Does It Really Mean to Be Healthy?

40:40 Why We Age in the First Place

48:05 Suresh's Definition of Health

57:26 Rapid Fire: Can Humans Reach 150?

58:08 The Best Form of Hormesis

1:02:07 How Healthcare Needs to Change

━━━━━💡 KEY QUESTIONS ANSWERED ━━━━

• Is aging really a disease?

• Are there actually genes that make us age?

• Why do we age if evolution favors survival?

• Does the longevity industry focus on the wrong problem?

• What does Suresh really think about Bryan Johnson, David Sinclair and longevity escape velocity?

• Can supplements or biohacks meaningfully slow aging?

• What is the real definition of health?

• Why is hormesis one of the most important concepts in healthy aging?

• Can humans realistically live to 150 years old?

• How should healthcare shift from treating disease to promoting health?

━━━━━Connect with Professor Suresh Rattan

LinkedIn: https://www.linkedin.com/in/suresh-rattan-7951804/

Most people think longevity is about living longer.

Dr. Jack Kreindler thinks that's exactly where we've gone wrong.

The longevity industry has never been bigger. Every week there's a new supplement, a new biomarker, a new biohack, or a new promise that you can slow aging.

But after more than 25 years working with elite athletes, founders, CEOs and patients facing life-threatening disease, Jack has reached a very different conclusion.

The goal isn't to live longer. It's to stay fully alive for as long as possible.

In this episode of Return on Health, hosts Niko Hems and Miguel Medina sit down with one of the world's leading physicians in preventive medicine and human performance to separate evidence from hype.

We explore why Jack has become one of the biggest critics of the word longevity, what he really thinks about Bryan Johnson and David Sinclair, whether NAD boosters actually make sense, and why purpose, relationships and resilience may be more powerful than the latest biohack.

━━━━━👤 ABOUT THE GUEST━━━━━

Dr. Jack Kreindler is a physician, physiologist and entrepreneur specializing in preventive medicine, human performance and healthy aging.

He is the Founder & CEO of WellFounded and previously founded the Centre for Health and Human Performance (CHHP) in London, where he pioneered a model combining elite sports science with clinical medicine.

Over the past two decades, he's worked with Olympic athletes, military personnel, founders, CEOs and patients with complex medical conditions - helping them maximize health, performance and resilience rather than simply adding years to life.

━━━━━🎙️ ABOUT THE HOSTS━━━━━━

Niko Hems

Niko Hems is a longevity expert and Head of Growth at YEARS, a company building a longitudinal, multi-modal health dataset to make prevention personal and data-driven.

Miguel Medina

Miguel Medina is co-host of Return on Health, a podcast built on a simple idea: a system always produces the outcomes it's incentivized to produce - so if we want better health outcomes, we need better incentives.

━━━━━━CHAPTERS━━━━━━

00:00 Why Jack Rejects the Word "Longevity"

01:33 What People Are Really Asking For

03:29 Healthspan vs. Lifespan

08:42 The Pillars That Actually Matter

12:02 What Happens Inside a Longevity Clinic

17:56 The Biomarkers Worth Paying Attention To

19:45 Why Human Connection Might Be the Ultimate Biomarker

28:25 Environmental Toxins & Modern Living

32:50 Are Toxins Really Making Us Sick?

36:14 Bryan Johnson, David Sinclair & Longevity Escape Velocity

40:03 What Founders Can Learn From Elite Performers

44:06 Burnout, Stress & High Performance

47:27 Can We Really Make 90 the New 60?

48:30 The Longevity Supplement Jack Would Never Take

49:40 The Supplements He Actually Recommends

51:15 Will AI Replace Doctors?

52:51 The Biggest Problem With Modern Healthcare

━━━━━💡 KEY QUESTIONS ANSWERED━━━

• Is the longevity industry focusing on the wrong goal?

• Can you actually extend your lifespan - or just your healthspan?• Are expensive longevity supplements worth the money?

• What does Jack really think about Bryan Johnson's Blueprint?

• Which supplements have the strongest evidence today?

• Why is VO₂ Max one of the most powerful predictors of long-term health?

• Are environmental toxins a bigger problem than we realize?

• Can AI become a better doctor than humans?

• Why might relationships, purpose and meaning outperform the latest biohacks?

• What would Jack change about modern healthcare if he could?

Connect with Jack

🌐 WellFoundedhttps://wellfounded.health

🏥 Centre for Health and Human Performance (CHHP)https://chhp.com

💼 LinkedInhttps://www.linkedin.com/in/jackkreindler/

Is the longevity supplement hype real - or are you wasting money? Bestselling author Bas Kast breaks down what actually works in nutrition, supplements, and slow aging.

Most people don't suffer from a lack of health advice. They suffer from too much of it. One expert says eat more protein, the next says cut animal foods. One says supplements are useless, the next sells a 100-pill longevity stack - and all of it sounds convincing.

In this episode of Return on Health, hosts Niko Hems and Miguel Medina sit down with Bas Kast - the science author whose book The Diet Compass (Der Ernährungskompass) sold over 1 million copies - to separate evidence from noise. We cover what still holds up in nutrition science, which supplements are worth taking (and which are pure marketing), why you are never the "average" person in a study, and Bas's new project SlowAger.

━━━━━━━━━━━━━━━

👤 ABOUT THE GUEST

━━━━━━━━━━━━━━━

Bas Kast is a science journalist and bestselling author known for translating complex nutrition and longevity research for a general audience - without academic jargon or wellness hype. His book "The Diet Compass" (Der Ernährungskompass) became an international bestseller with 1M+ copies sold, grounded in thousands of peer-reviewed studies. His newer work focuses on vitamins and supplements (the "Vitamin Compass" / Der Vitamin-Kompass), and his current project, SlowAger, explores the messy intersection of nutrients, supplements and healthy aging.

━━━━━━━━━━━━━━━

🎙️ ABOUT THE HOSTS

━━━━━━━━━━━━━━━

Niko Hems is a longevity expert and Head of Growth at YEARS, a company building a longitudinal, multi-modal health dataset to make prevention personal and data-driven.

Miguel Medina is co-host of Return on Health, a podcast built on a simple idea: a system always produces the outcomes it's incentivized to produce - so if we want better health outcomes, we need better incentives.

━━━━━━━━━━━━━━━

⏱️ CHAPTERS

━━━━━━━━━━━━━━━

00:00 Too much health advice — the real problem with health information

01:18 How Bas Kast got into nutrition: headaches, low-carb & a personal wake-up call

05:15 Where health communication goes wrong: incentives & the Brian Johnson effect

12:19 The 3 principles of healthy eating (Michael Pollan's rule explained)

15:04 What Bas changed his mind on: whole grains, the gluten myth, cheese & intermittent fasting

21:01 Population data vs. personalization: why nutrition averages mislead you

28:28 A data-driven future for nutrition, CGMs & the 10-year Diet Compass update

33:25 The supplement hype: do we really need supplements? (NMN, NR, spermidine, taurine)

44:48 SlowAger, low-dose lithium & how to weigh risk vs. caution

51:06 Lightning round: 3 steps to use supplements intelligently

52:39 The most underrated supplement category (AREDS, lutein & zeaxanthin for eye health)

57:20 Return on Health: the one thing to fix in medicine — treat your body like your teeth

━━━━━━━━━━━━━━━

💡 KEY QUESTIONS ANSWERED

━━━━━━━━━━━━━━━

- Do longevity supplements like NMN, NR and spermidine actually work?

- What are the 3 simple rules for a healthy diet?

- Is gluten bad for you if you're not sensitive?

- Why does the same diet work for one person and fail for another?

- Which supplements are actually backed by strong evidence?

- Is low-dose lithium safe as a supplement?

- Why is the medical system "too reactive" — and how do we fix it?

━━━━━━━━━━━━━━━

🔗 LINKS

━━━━━━━━━━━━━━━

📚 Bas Kast - The Vitamin Compass: https://vitaminkompass.com/

🔔 Subscribe for a new episode every week

Functional Medicine MD: What 5,000+ Patients Taught Him About Root Cause Medicine

In this episode of Return on Health, we speak with Dr. Peter Martin, physician, former CNS pharmacology researcher, and founder of FunMed, one of Europe’s leading functional medicine clinics.

Peter spent around 15 years in pharmacology research before his own burnout pushed him to look beyond the conventional model of symptom control. What started as a personal search for recovery became a data-driven clinical model built around root cause medicine, extensive biomarker testing, gut health, metabolism, and chronic disease prevention.

We talk about what functional medicine actually means, why chronic disease often needs a different care model, and what Peter has learned from treating more than 5,000 patients. He explains why fasting insulin may be one of the most overlooked markers in modern healthcare, how low-grade inflammation is often connected to gut health, and why normal lab results do not always mean someone is truly healthy.

We also get into the controversial parts: large biomarker panels, false positives, red meat, vegan diets, anti-nutrients, carnivore diets, and the weakness of much nutrition research. Peter also shares why he believes functional medicine could become part of the European healthcare system, especially if reimbursement shifts from visits and procedures toward actual health outcomes.

This episode covers:

• What 5,000+ patients taught him

• Why fasting insulin is often missed

• How root cause medicine could change care

Topics discussed:

00:00 Introduction
01:00 What FunMed does differently
02:00 Real-world data from 5,000+ patients
03:30 From CNS pharmacology to functional medicine
07:00 Root cause medicine vs symptom control
10:30 Precision health in Sweden and Germany
15:30 Why FunMed tests around 200 biomarkers
21:00 False positives and the problem with large panels
28:00 Fasting insulin and insulin resistance
31:00 Low-grade inflammation and gut health
35:30 Low-carb and ancestral nutrition
41:00 Vegan diets, nutrient deficiencies, and bio-individuality
49:30 Red meat, nutrition research, and epidemiology
56:00 Functional medicine and insurance coverage
59:00 Rapid fire: biomarkers, magnesium, carnivore diet, healthcare reform

Guest

Dr. Peter Martin

Physician, former CNS pharmacology researcher, founder of FunMed, and one of the leading voices trying to bring functional medicine and precision health into European healthcare.

Guest links

LinkedIn: https://www.linkedin.com/in/peter-martin-31b23342/
FunMed: https://www.funmed.se/?srsltid=AfmBOorlgUNnEK1ba7p_zIxug35sx3YMSq6PmYiufq6xJH1VAQ-EiQc0

Return on Health is available wherever you get your podcasts.

If you enjoyed this episode, leaving a 5-star rating on Spotify helps us bring more honest conversations about health, longevity, and medicine to more people.

Harvard MD: The Peptide Boom Is Here.. But Is Medicine Ready?

In this episode of Return on Health, Niko and Miguel speak with Dr. Anand Vinjamoori, Harvard Medical School and Harvard Business School trained physician, former founding Chief Medical Officer at Modern Age, advisor to Superpower, and founder of Next Generation Medicine.

Together, they discuss why longevity medicine is booming while many companies still struggle to build sustainable businesses, why peptides may become one of the next major waves in health optimization, and why the future of biomarkers will likely require a much more individualized and data-driven approach.

This episode covers:

The peptide boom and why it matters
Why longevity businesses often fail
What biomarkers can and cannot tell us

Dr. Anand explains why the current medical evidence system may be too slow for the next generation of therapies, how real-world data and patient registries could help close the evidence gap, and why biomarkers should be used with nuance rather than treated as absolute truth. He also shares his view on overhyped interventions, the role of exercise, and the cultural differences between American optimization culture and European lifestyle rhythms.

Key topics

Longevity medicine and market timing
The business challenges behind longevity clinics
Customer acquisition and why messaging matters
The rise of peptides in health optimization
Evidence gaps, real-world data, and patient registries
Personalized medicine and individual risk assessment
Biomarkers, multi-omics, and biological individuality
Why HBA1c can be overinterpreted
Exercise as one of the strongest health interventions
Cold plunges and the problem of overapplied hormesis
European lifestyle culture vs. American optimization culture

Chapters

00:00 The Longevity Paradox
01:03 Building Modern Age and the Early Longevity Market
05:04 Personal Motivations Behind Longevity Medicine
07:57 What Patients Actually Want From Longevity Care
11:39 Why Many Longevity Businesses Struggle
15:12 How Customer Preferences Have Changed
18:21 Peptides as the Next Big Wave
19:07 Peptides, Regulation, and Medical Experimentation
24:24 The Evidence Gap in Peptide Use
30:58 Why Medicine Needs Better Risk Assessment
36:59 Biomarkers and Biological Ground Truth
44:20 Multi-Omics and the Future of Measurement
48:35 Which Biomarkers Are Useful — And Which Are Noise?
52:42 Culture, Lifestyle, and Health Optimization
55:45 Lightning Round: Metrics, Interventions, and Healthcare Reform

Guest

Dr. Anand VinjamooriHarvard Medical School and Harvard Business School trained physician, former founding Chief Medical Officer at Modern Age, advisor to Superpower, and founder of Next Generation Medicine.

Guest links

LinkedIn: https://www.linkedin.com/in/vinjamoori/
Next Generation Medicine: https://www.nextgenerationmedicine.co/
Superpower: https://www.linkedin.com/company/superpower/posts/?feedView=all

Listen now

Return on Health is available wherever you get your podcasts.

If you enjoyed this episode, leaving a 5-star rating on Spotify helps us bring more honest conversations about health, longevity, and medicine to more people.